The FOXS1/CXCL8 axis promoted tumor cell migration, invasion, angiogenesis, and metastasis in CRC, suggesting that FOXS1/CXCL8 may be a novel target in disrupting tumor-associated angiogenesis and in controlling advanced CRC. The gene discussed is CXCL8; the disease is neoplasm.